Soblidotin

DB12677InvestigationalSmall molecule

Soblidotin has been used in trials studying the treatment of Sarcoma, Lung Cancer, and Unspecified Adult Solid Tumor, Protocol Specific.

Chemical structure of Soblidotin
Mechanism
Curator reviewed
Formula / weight
C39H67N5O6 · 701.994 g/mol (avg)
Code names
TZT-1027

Resolves to

Compound
UNIIDQC51A0WQHCAS149606-27-9ChEMBLCHEMBL3989512PubChem6918315
Structure
InChIKeyDZMVCVHATYROOS-ZBFGKEHZSA-NSMILESCC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCC1=CC=CC=C1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Soblidotin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In